Veterinary and animal pharmaceutical companyDechra Pharmaceuticals(DPH) has made a radical change to its business by selling off its veterinary services business to US-firm Patterson Companies Inc for £87.5m. The deal, which is subject to shareholder approval, will help the company to largely clear its £102m net debt and allow it to concentrate on its much higher margin pharmaceutical business.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis